Trial · NCT01228903

Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk	Events
other	gout	Musculoskeletal and connective tissue disorders	Control	1	41
other	gout	Musculoskeletal and connective tissue disorders	Allopurinol	1	39
other	GI discomfort	Gastrointestinal disorders	Control	2	41
other	GI discomfort	Gastrointestinal disorders	Allopurinol	2	39
other	rash	Skin and subcutaneous tissue disorders	Control	2	41
other	rash	Skin and subcutaneous tissue disorders	Allopurinol	0	39
other	Abnormal Liver Function Tests	Hepatobiliary disorders	Control	2	41
other	Abnormal Liver Function Tests	Hepatobiliary disorders	Allopurinol	0	39
other	Thrombocytopenia	Blood and lymphatic system disorders	Control	2	41
other	Thrombocytopenia	Blood and lymphatic system disorders	Allopurinol	1	39
serious	Death	Cardiac disorders	Control	0	41	0
serious	Death	Cardiac disorders	Allopurinol	1	39	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01228903/events